Serum levels of anti-PLA2R antibody are a potentially useful marker for the prediction of diagnosis and for monitoring the treatment response in Primary Membranous Nephropathy (PMN). Among patients with chronic kidney disease (CKD) awaiting kidney transplantation, higher levels of anti-PLA2R could predict those more likely to recur after transplantation.